Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A health care worker administering a coronavirus vaccine in Modi'in-Maccabim-Re'ut, Israel, on July 5. Photo: Gil Cohen Magen/Xinhua via Getty Images

Israel on Monday will begin offering a third dose of Pfizer and BioNTech's coronavirus vaccine as a booster shot for people with weakened immune systems, according to the Times of Israel.

Why it matters: It's one of the first countries to offer booster shots to bolster protection against the rapidly spreading Delta variant. The Israeli Health Ministry is still determining whether an extra shot should be offered to the general public.

  • Despite a world-leading vaccine rollout, new coronavirus cases have surged in Israel over the past month in part because of the highly contagious Delta variant.
  • Israel's Health Ministry announced last week that the effectiveness of the Pfizer vaccine had dropped to 64% against all COVID-19 infections, down from 95% in May.

What they're saying: World Health Organization Director-General Tedros Adhanom Ghebreyesus on Monday criticized the notion of administering booster doses in high-income countries when many low-income countries are struggling with gaining access to first doses.

  • "We’re making conscious choices right now not to protect those in most need,” Tedros said. "Currently, data shows us that vaccination offers long-lasting immunity against severe and deadly COVID-19. The priority now must be to vaccinate those who have received no doses and protection."
  • "Instead of Moderna and Pfizer prioritizing the supply of vaccine as boosters to countries whose populations have relatively high coverage, we need them to go all out to channel supply to COVAX, the Africa Vaccine Acquisition Task Team and low- and middle-income countries which have very low vaccine coverage," he continued.

The big picture: Pfizer and BioNTech announced last week that they will seek authorization to offer an updated booster shot in the United States and European countries.

  • Pfizer also released the results of a study on booster shots, finding that a third dose was 5–10 times more effective at neutralizing the virus than two doses because of "an observed decline in efficacy against symptomatic disease over time."

Go deeper ... Study: Delta coronavirus variant evades antibodies through mutations

Correction: This story has been updated to remove references to Israel being the first country to offer a third booster shot. Turkey and several other countries offered boosters after Chinese-made vaccines provided weak protection against COVID.

Go deeper

Sep 20, 2021 - World

Biden to push vaccine-sharing at UN, but boosters at home

Expand chart
Data: Our World in Data; Chart: Kavya Beheraj/Axios

President Biden will convene world leaders on Wednesday on the sidelines of the UN General Assembly to push them to do more to end the pandemic — though he's also facing criticism for prioritizing boosters at home.

Why it matters: There is still no functional plan in place to vaccinate the world, and past summits of this sort have flopped. The White House hopes that this virtual gathering will produce ambitious promises, accountability measures to track progress, and ultimately help achieve a 70% global vaccination rate this time next year.

Updated 14 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Biden to get booster shot on camera — Pfizer vaccine safe, effective in children, company says — The booster vaccine discussion is far from over.
  2. Health: Study: Pandemic cut U.S. life expectancy by more than 9 million years — U.S. death toll surpasses 1918 flu fatalities — Chicago has highest case rates in city worker neighborhoods.
  3. Politics: Biden to push vaccine-sharing at UN, but boosters at home — Rep. Tim Ryan tests positive — Biden administration to lift travel ban for fully vaccinated international travelers.
  4. Education: D.C. schools to require teachers, staff to receive vaccine without testing option — More schools using "test-to-stay" strategy to minimize quarantines.
  5. Variant tracker: Where different strains are spreading.

Rep. Tim Ryan tests positive for coronavirus

Photo: Bill Clark/CQ-Roll Call, Inc via Getty Images

Rep. Tim Ryan (D-Ohio) said Monday that he has tested positive for the coronavirus, and that his vaccination against the virus prevented a more severe infection.

What they're saying: "Today, I tested positive for COVID-19," Ryan wrote on Twitter. "While I’m currently experiencing mild symptoms, I’m grateful to have the protection of a safe and effective vaccine — and I know without it, this illness could be much, much worse."

  • "What we have learned over the last year and a half is that we are in this together, and I urge all Ohioans to help us crush this pandemic by wearing a mask and getting vaccinated so that we can get back to normal."